EOM Pharmaceuticals Holdings, Inc.

EOM Pharmaceuticals Holdings, Inc. - PE Ratioverified

IMUC

Price:

$0.1621

Market Cap:

$20.51M

EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company’s lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as well as in Phase ½ a clinical trial to treat infectious diseases, such as COVID-19. It also develops EOM 147, an investigational broad-spectrum amino...[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

IMUC

The PE Ratio as of September 2026 (TTM) for EOM Pharmaceuticals Holdings, Inc. (IMUC) is -0.04

According to EOM Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -99.84% compared to the average of -25.25 of the last 4 quarters.

EOM Pharmaceuticals Holdings, Inc. (IMUC) Historical PE Ratio (quarterly & annually)

How has IMUC PE Ratio performed in the past?

The mean historical PE Ratio of EOM Pharmaceuticals Holdings, Inc. over the last ten years is -8.82. The current -0.04 PE Ratio has changed -54.64% with respect to the historical average. Over the past ten years (40 quarters), IMUC's PE Ratio was at its highest in in the September 2011 quarter at 0.10. The PE Ratio was at its lowest in in the December 2022 quarter at -49.98.

Quarterly (TTM)
Annual

Average

-8.82

Median

-5.89

Minimum

-35.03

Maximum

-0.01

EOM Pharmaceuticals Holdings, Inc. (IMUC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of EOM Pharmaceuticals Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 13.63%

Maximum Annual PE Ratio = -0.01

Minimum Annual Increase = -54.62%

Minimum Annual PE Ratio = -35.03

Quarterly (TTM)
Annual
YearPE RatioChange
2025-4.67-54.62%
2024-10.29-37.00%
2023-16.34-53.36%
2022-35.03392.09%
2021-7.12-51.23%
2020-14.6013.63%
2017-0.111.79%
2016-0.01-29.08%
2015-0.018.11%
2014-0.010.59%

EOM Pharmaceuticals Holdings, Inc. (IMUC) Average PE Ratio

How has IMUC PE Ratio performed in the past?

The current PE Ratio of EOM Pharmaceuticals Holdings, Inc. (IMUC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-10.43

5-year avg

-14.69

10-year avg

-8.82

EOM Pharmaceuticals Holdings, Inc. (IMUC) PE Ratio vs. Peers

How is IMUC’s PE Ratio compared to its peers?

EOM Pharmaceuticals Holdings, Inc.’s PE Ratio is greater than Sirona Biochem Corp. (-0.71), greater than Nymox Pharmaceutical Corporation (-0.45), greater than Hemostemix Inc (-2.83), greater than HOOKIPA Pharma Inc. (-0.71), greater than Algorae Pharmaceuticals Limited (-9.00), greater than Devonian Health Group Inc. (-3.76), greater than PreveCeutical Medical Inc. (-16.67), less than Propanc Biopharma, Inc. (-0.02), greater than Oxford BioDynamics Plc (-0.29), less than Quest PharmaTech Inc. (1.01),

Build a custom stock screener for EOM Pharmaceuticals Holdings, Inc. (IMUC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EOM Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

EOM Pharmaceuticals Holdings, Inc. (IMUC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like EOM Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is EOM Pharmaceuticals Holdings, Inc.'s PE Ratio?

How is the PE Ratio calculated for EOM Pharmaceuticals Holdings, Inc. (IMUC)?

What is the highest PE Ratio for EOM Pharmaceuticals Holdings, Inc. (IMUC)?

What is the 3-year average PE Ratio for EOM Pharmaceuticals Holdings, Inc. (IMUC)?

What is the 5-year average PE Ratio for EOM Pharmaceuticals Holdings, Inc. (IMUC)?

How does the current PE Ratio for EOM Pharmaceuticals Holdings, Inc. (IMUC) compare to its historical average?